LEGAL ASPECTS OF CLINICAL TRIALS IN POLAND
Katarzyna Syroka-Marczewska
Institute of Criminal Law, Faculty of Law and Administration, University of Warsaw , PolandAbstract
A clinical trial is each trial conducted in humans to discover or confirm the clinical, pharmacological, including pharmacodynamic, effects of action of one or more investigational medicinal products, or to identify the adverse reactions to one or more investigational medicinal products, or to monitor absorption, distribution, metabolism and excretion of one or more investigational medicinal products, taking into consideration their safety and efficacy. It ought to be remembered that clinical trials may be conducted with the use of medicinal products. Clinical trials must be conducted in a way which is in line with the primary principle that clinical trial participants’ rights, safety, health, and welfare override the interest of science and society.
Keywords:
clinical trials, medicinal products, pharmacovigilance, pharmaceutical lawReferences
Drozdowska Joanna, Consent of medicinal product clinical trial participant, [in:] M. Śliwka (ed.), An Outline of Clinical Trials Law, Toruń 2013.
Haberko Joanna, Witness to consent for diagnostic and therapeutic activities comprising medical experiment in the light of Act on the professions of Doctor and Dentist and Pharmaceutical Law, Law and Medicine 2009, no 3.
Ignaczewski Jacek, Patient’s Consent to Treatment, Warsaw 2003.
M. Świderska, Patient’s Consent to Healthcare Intervention, Toruń 2007.
Janiszewska Beata, Patient’s Welfare or Patient’s Will – legal and medical dilemma (remarks on refusal to give consent to treatment and admissibility of living will statements), Law and Medicine no 2, 2007.
Karkowska Dorota, Act on Patients’ Rights and Commissioner for Patients’ Rights. Commentary, LEX on-line, commentary to Article 12a, paragraph 3, sentence 5.
Kondrat Mariusz (ed.), Pharmaceutical Law. Commentary, Warsaw 2016.
Kubiak Rafał, Experiment Participant Consent, Law and Medicine 2000, no 8.
Łagocka Iwona, Maciejczyk Agata (ed.), Pharmacovigilance, Warsaw 2008.
Maciejczuk Agata, Arcab Anna, Pharmacovigilance – legal provisions, [in:] Pharmacovigilance I. Łagocka, A. Maciejczyk (ed.), Warsaw 2008.
Masełbas Wojciech, Adverse Drug Reactions: definitions, causes, classification, [in:] Pharmacovigilance, I. Łagocka, A. Maciejczyk (ed.), Warsaw 2008.
Masełbas Wojciech, [in:] M. Kondrat (ed.), Pharmaceutical Law. Commentary, Warsaw, 2009.
Mąkosa M., Expected impact of Regulation 536/2014 on clinical trials in Poland, http://www.badaniaklinicznewpolsce.pl/konferencja-badania-kliniczne--nowe-otwarcie/.
Nurczyńska Anna, Damage caused as a result of clinical trials in trail participant (patient) in the light of amended pharmaceutical law regulations, http://www.prawoimedycyna.pl/?str=artykul&id=1037.
Olszewski Wojciech L. (ed.), Pharmaceutical Law. Commentary, Warsaw 2016.
Sławatyniec Łukasz (ed.), Pharmaceutical Law Medicines Reimbursement, Warsaw 2013.
Siwiec M., Differences Between Medicinal Products, Food Supplements, Medical Devices and Foodstuffs for Particular Purposes. Practical Commentary, LEX on-line.
Szpunar A., Consent of an entitled person in the scope of personal rights protection, Legal, Economic and Sociological Gazette no 1, 1990, p. 46.
Institute of Criminal Law, Faculty of Law and Administration, University of Warsaw
